HBIO
Harvard Bioscience·NASDAQ
--
--(--)
--
--(--)
HBIO Filings
Filing Date
Form Description
Form Type
2026-03-06
Form 8-K - Current report
Key Events
2026-03-06 · Key Events
Form 8-K - Current report
2026-02-12
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-12 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-10
Form 8-K - Current report
Key Events
2026-02-10 · Key Events
Form 8-K - Current report
2026-02-10
Form EFFECT - Notice of Effectiveness
2026-02-10 ·
Form EFFECT - Notice of Effectiveness
2026-02-09
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-02-09 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-01-30
Form DEF 14A - Other definitive proxy statements
Key Events
2026-01-30 · Key Events
Form DEF 14A - Other definitive proxy statements
2026-01-30
Form S-3 - Registration statement under Securities Act of 1933
2026-01-30 ·
Form S-3 - Registration statement under Securities Act of 1933
2026-01-29
Form 8-K - Current report
Key Events
2026-01-29 · Key Events
Form 8-K - Current report
2026-01-20
Form PRE 14A - Other preliminary proxy statements
Key Events
2026-01-20 · Key Events
Form PRE 14A - Other preliminary proxy statements
2026-01-20
Form 8-K - Current report
Key Events
2026-01-20 · Key Events
Form 8-K - Current report
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
